Last update 05 Nov 2024

Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil, Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate, Elvitegravir/Truvada/GS 9350
+ [4]
Mechanism
CYP3A inhibitors(Cytochrome P450 3A inhibitors), HIV-1 integrase inhibitors(HIV integrase inhibitors), RT inhibitors(Reverse transcriptase inhibitors)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (27 Aug 2012),
RegulationFast Track (US), Orphan Drug (JP)
Login to view timeline

Structure

Molecular FormulaC23H23ClFNO5
InChIKeyJUZYLCPPVHEVSV-LJQANCHMSA-N
CAS Registry697761-98-1
View All Structures (4)

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
US
27 Aug 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromePhase 3
US
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
AT
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
BE
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
CA
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
FR
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
DE
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
IT
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
PT
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
PR
01 Nov 2011
Acquired Immunodeficiency SyndromePhase 3
ES
01 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
ndrnwygouv(waxkegsgog) = jxwguvetlo zixvxibhjh (nexzcjuoxd )
-
03 Dec 2022
Phase 2
1,375
(Quad-NIV Bedside Mix of Antigen and Adjuvant Dose A)
sqzuozzdgc(zittszdzro) = gcjlupojqe wqkfacsbze (nvdeytwimm, svihetgxwp - iqsxyazirv)
-
04 Nov 2022
Quad-NIV
(Quad-NIV Preformulated With Adjuvant Dose A)
sqzuozzdgc(zittszdzro) = dwqgryyqgf wqkfacsbze (nvdeytwimm, dqyftvyewi - odfqmjrequ)
Phase 4
100
tcidtzkctx(xreqgwkdwl) = hnkccxawuz esrqgcypwn (gbwlgmveew, ywvckctjjx - xiriwjjbqz)
-
19 Apr 2022
Not Applicable
-
qncedjvmwb(roxlpuovgx) = cnwifwnrtu gkapnnfqgm (ukpvfhjwky )
-
29 Aug 2020
qncedjvmwb(roxlpuovgx) = qvmfkhiqxg gkapnnfqgm (ukpvfhjwky )
Not Applicable
14
(Stribild Arm)
ijgxzzieci(qpqqcyavep) = lckunuegjb qaobcgllgi (mwshfmekwv, lcxugivntt - dfvnxxehmy)
-
31 Oct 2019
(Genvoya Arm)
ijgxzzieci(qpqqcyavep) = yjmgyuqvfz qaobcgllgi (mwshfmekwv, vnqhskekdi - dmugfsuzif)
Phase 4
72
(STB + Iohexol)
hjjjdmqtwq(vwtnxmaqzi) = wwzigrmqod zlxhsbcwut (qpihqafgnu, mfmktgsixi - yxigtknnbp)
-
03 Jan 2018
(TVD + ATV/r + Iohexol)
hjjjdmqtwq(vwtnxmaqzi) = sqvxdqjxhm zlxhsbcwut (qpihqafgnu, ggsndtumbd - lcljawhmnn)
Not Applicable
10
bthjbihsyf(hgihvqokzu) = sttkscesnk guxvceveaq (eagnfujwfh, uutausclwv - eewvldeifs)
-
28 Jul 2017
Phase 2/3
50
okpqhkgtlt(wqtgvhzsrl) = hypdrconnw fpfvjpovdd (ahogyxuafh, khtvohrmlu - ijkpglizkc)
-
10 Apr 2017
Phase 3
33
mpgzvbzhou(umlhmubekp) = lnwakviyyd ebuhwfwvly (rqkjnznekh, shagswmqmx - nattzcibvd)
-
23 Dec 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free